Abstract

Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study

Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana

Issue: Mar/Apr 2023 - Volume 27, Number 2

Page(s): 108-112

Download in electronic PDF format for $75

Abstract

A postmenopausal female patient was suffering from vulvovaginal symptoms such as dryness and irritation, which were affecting her relationship with her partner and her overall quality of life. The patient was instructed to apply an estriol 0.1% vaginal ointment (PCCA Ellage Anhydrous Vaginal) for a duration of three months. The safety and efficacy of the compounded treatment were evaluated using an online data collection form, which included the validated Vulvovaginal Symptom Questionnaire. Post-treatment results show that the vulvovaginal symptoms were no longer bothersome, and that the patient’s relationship was no longer affected. There were no reports of undesirable effects as a result of the compounded treatment. This case study reinforces the benefits and convenience of using topical hormone replacement therapy in postmenopausal women.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2023 Pg. 108-112	Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Jan/Feb 2004 Pg. 16-21	Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 Author(s): Cutter Christopher B
Nov/Dec 2010 Pg. 465-471	The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women Author(s): Bramwell Bethany L
Jul/Aug 2008 Pg. 295-304	Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Mar/Apr 2004 Pg. 96-99	Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 Author(s): Cutter Christopher B
Nov/Dec 2018 Pg. 456-465	Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome Author(s): Riepl Mike
Sep/Oct 2003 Pg. 330-338	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Author(s): Gillson George R, Zava David T
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Jan/Feb 2019 Pg. 77-81	Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2017 Pg. 6-16	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Author(s): Deleruyelle Laura J
Sep/Oct 1999 Pg. 357-359	Women's Health Book Reviews Author(s): Reed-Kane Dana
Nov/Dec 2004 Pg. 427-435	The Salivary Hormone Profile in the Clinical Evaluation of Women Author(s): Stephenson Kenna
Jul/Aug 2002 Pg. 255-256	Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Author(s): Mason Dave
Jan/Feb 2014 Pg. 70-77	The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study Author(s): Ruiz Andres D, Daniels Kelly R
Nov/Dec 2009 Pg. 556	Gentian Violet Vaginal Suppositories Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 165-170	Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Author(s): Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Sep/Oct 2008 Pg. 450	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr